Long-term efficacy of two sequential induction courses of Bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer

被引：0

作者：

Seo, Ho Kyung ^{[1
]}

Jung, Eui Hyun ^{[1
]}

Song, Geehyun ^{[1
]}

机构：

[1] Natl Canc Ctr, Res Inst, Hosp Div Tumor Immunol, Ctr Urol Canc,Dept Urol, Goyang, Gyeonggi Do, South Korea

来源：

TRANSLATIONAL ANDROLOGY AND UROLOGY | 2025年 / 14卷 / 01期

关键词：

Bacillus Calmette-Gu & eacute; rin therapy (BCG therapy); non-muscle-invasive bladder cancer (NMIBC); biomarkers; management; CALMETTE-GUERIN; MAINTENANCE; CARCINOMA; T1; TA; THERAPY; BCG;

D O I：

10.21037/tau-24-466

中图分类号：

R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

摘要：

引用

页码：4 / 7

页数：4

共 17 条

[1] Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin- unresponsive High-risk Non-muscle-invasive Bladder Cancer: SWOG S1605 [J].

Black, Peter C. ;

Tangen, Catherine M. ;

Singh, Parminder ;

McConkey, David J. ;

Lucia, M. Scott ;

Lowrance, William T. ;

Koshkin, Vadim S. ;

Stratton, Kelly L. ;

Bivalacqua, Trinity J. ;

Kassouf, Wassim ;

Porten, Sima P. ;

Bangs, Rick ;

Plets, Melissa ;

Thompson, Ian M. ;

Lerner, Seth P. .

EUROPEAN UROLOGY, 2023, 84 (06) :536-544

[2] Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial [J].

Boorjian, Stephen A. ;

Alemozaffar, Mehrdad ;

Konety, Badrinath R. ;

Shore, Neal D. ;

Gomella, Leonard G. ;

Kamat, Ashish M. ;

Bivalacqua, Trinity J. ;

Montgomery, Jeffrey S. ;

Lerner, Seth P. ;

Busby, Joseph E. ;

Poch, Michael ;

Crispen, Paul L. ;

Steinberg, Gary D. ;

Schuckman, Anne K. ;

Downs, Tracy M. ;

Svatek, Robert S. ;

Mashni, Joseph, Jr. ;

Lane, Brian R. ;

Guzzo, Thomas J. ;

Bratslavsky, Gennady ;

Karsh, Lawrence I. ;

Woods, Michael E. ;

Brown, Gordon ;

Canter, Daniel ;

Luchey, Adam ;

Lotan, Yair ;

Krupski, Tracey ;

Inman, Brant A. ;

Williams, Michael B. ;

Cookson, Michael S. ;

Keegan, Kirk A. ;

Andriole, Gerald L., Jr. ;

Sankin, Alexander I. ;

Boyd, Alan ;

O'Donnell, Michael A. ;

Sawutz, David ;

Philipson, Richard ;

Coll, Ruth ;

Narayan, Vikram M. ;

Treasure, F. Peter ;

Yla-Herttuala, Seppo ;

Parker, Nigel R. ;

Dinney, Colin P. N. .

LANCET ONCOLOGY, 2021, 22 (01) :107-117

[3]

Chamie K, 2022, NEJM EVID, V2, DOI [10.1056/evidoa2200167, 10.1056/EVIDoa2200167]

[4] Efficacy of Different Bacillus of Calmette-Guerin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis [J].

Del Giudice, Francesco ;

Asero, Vincenzo ;

Bologna, Eugenio ;

Scornajenghi, Carlo Maria ;

Carino, Dalila ;

Dolci, Virginia ;

Viscuso, Pietro ;

Salciccia, Stefano ;

Sciarra, Alessandro ;

D'Andrea, David ;

Pradere, Benjamin ;

Moschini, Marco ;

Mari, Andrea ;

Albisinni, Simone ;

Krajewski, Wojciech ;

Szydelko, Tomasz ;

Malkiewicz, Bartosz ;

Nowak, Lukasz ;

Laukhtina, Ekaterina ;

Gallioli, Andrea ;

Mertens, Laura S. ;

Marcq, Gautier ;

Cimadamore, Alessia ;

Afferi, Luca ;

Soria, Francesco ;

Mori, Keiichiro ;

Tully, Karl Heinrich ;

Pichler, Renate ;

Ferro, Matteo ;

Tataru, Octavian Sabin ;

Autorino, Riccardo ;

Crivellaro, Simone ;

Crocetto, Felice ;

Busetto, Gian Maria ;

Basran, Satvir ;

Eisenberg, Michael L. ;

Chung, Benjamin Inbeh ;

De Berardinis, Ettore .

CANCERS, 2023, 15 (07)

[5] The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin Instillation Therapy on the Quality of Life in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial [J].

Gontero, Paolo ;

Oderda, Marco ;

Mehnert, Anja ;

Gurioli, Alberto ;

Marson, Francesco ;

Lucca, Ilaria ;

Rink, Michael ;

Schmid, Marianne ;

Kluth, Luis A. ;

Pappagallo, Giovanni ;

Sogni, Filippo ;

Sanguedolce, Francesco ;

Schiavina, Riccardo ;

Martorana, Giuseppe ;

Shariat, Shahrokh F. ;

Chun, Felix .

JOURNAL OF UROLOGY, 2013, 190 (03) :857-862

[6] Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS" [J].

Grimm, Marc-Oliver ;

van der Heijden, Antoine G. ;

Colombel, Marc ;

Muilwijk, Tim ;

Martinez-Pineiro, Luis ;

Babjuk, Marko M. ;

Turkeri, Levent N. ;

Palou, Joan ;

Patel, Anup ;

Bjartell, Anders S. ;

Caris, Christien ;

Schipper, Raymond G. ;

Witjes, Wim P. J. ;

Horstmann, Joerg ;

Machtens, Stefan ;

Mumperow, Eberhard ;

Al Ghazal, Andreas ;

Pulte, Thomas ;

Stephan-Odenthal, Michael ;

Gakis, Georgios ;

Kramer, Mario ;

Zaak, Dirk ;

Schmitz-Draeger, Bernd ;

Schreier, Holger ;

Lehmann, Jan ;

Werner, Torsten ;

Klier, Joerg ;

Marin, Jan ;

Rulf, Wolfgang ;

Hellmis, Eva ;

Schneider, Andreas ;

Spiegelhalder ;

Wirth, Manfred ;

Klotz, Theodor ;

Suttmann, Henrik ;

Siebels, Michael ;

Rodemer, Gerd ;

Rudolph, Robert ;

Zillmann, Roger ;

de Bruin, M. ;

Bos, S. ;

van Moorselaar, R. ;

de Reijke, T. ;

Boormans, J. ;

Wijsman, B. ;

van Melick, H. H. E. ;

van Boven, E. ;

Meijer, R. P. ;

van der Heijden, A. G. ;

Vergunst, H. .

EUROPEAN UROLOGY, 2020, 78 (05) :690-698

[7] KEYNOTE-676: Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBC [J].

Kamat, Ashish M. ;

Shore, Neal ;

Hahn, Noah ;

Alanee, Shaheen ;

Nishiyama, Hiroyuki ;

Shariat, Shahrokh ;

Nam, Kijoeng ;

Kapadia, Ekta ;

Frenkl, Tara ;

Steinberg, Gary .

FUTURE ONCOLOGY, 2020, 16 (10) :507-516

[8] Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group [J].

Kamat, Ashish M. ;

Sylvester, Richard J. ;

Bohle, Andreas ;

Palou, Joan ;

Lamm, Donald L. ;

Brausi, Maurizio ;

Soloway, Mark ;

Persad, Raj ;

Buckley, Roger ;

Colombel, Marc ;

Witjes, J. Alfred .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (16) :1935-+

[9] Response to 2 Induction Courses of Bacillus Calmette-Guèrin Therapy Among Patients With High-Risk Non-Muscle-Invasive Bladder Cancer [J].

Katims, Andrew B. ;

Tallman, Jacob ;

Vertosick, Emily ;

Porwal, Shaun ;

Dalbagni, Guido ;

Cha, Eugene K. ;

Smith, Robert ;

Benfante, Nicole ;

Herr, Harry W. .

JAMA ONCOLOGY, 2024, 10 (04) :522-525

[10] Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group study [J].

Lamm, DL ;

Blumenstein, BA ;

Crissman, JD ;

Montie, JE ;

Gottesman, JE ;

Lowe, BA ;

Sarosdy, MF ;

Bohl, RD ;

Grossman, HB ;

Beck, TM ;

Leimert, JT ;

Crawford, ED .

JOURNAL OF UROLOGY, 2000, 163 (04) :1124-1129

← 1 2 →